Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases.

Boyd CM, Vollenweider D, Puhan MA.

PLoS One. 2012;7(8):e41601. doi: 10.1371/journal.pone.0041601. Epub 2012 Aug 3. Review.

2.

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Kew KM, Dias S, Cates CJ.

Cochrane Database Syst Rev. 2014 Mar 26;(3):CD010844. doi: 10.1002/14651858.CD010844.pub2. Review.

PMID:
24671923
3.

Long-acting beta2-agonists for chronic obstructive pulmonary disease.

Kew KM, Mavergames C, Walters JA.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD010177. doi: 10.1002/14651858.CD010177.pub2. Review.

PMID:
24127118
4.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Nannini LJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD006829. doi: 10.1002/14651858.CD006829.pub2. Review.

5.

Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews.

Reid WD, Yamabayashi C, Goodridge D, Chung F, Hunt MA, Marciniuk DD, Brooks D, Chen YW, Hoens AM, Camp PG.

Int J Chron Obstruct Pulmon Dis. 2012;7:297-320. doi: 10.2147/COPD.S29750. Epub 2012 May 14.

6.

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Kew KM, Seniukovich A.

Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Review.

PMID:
24615270
7.

Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Welsh EJ, Evans DJ, Fowler SJ, Spencer S.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010337. doi: 10.1002/14651858.CD010337.pub2. Review.

PMID:
26171905
8.

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

Chong J, Karner C, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009157. doi: 10.1002/14651858.CD009157.pub2. Review.

PMID:
22972134
9.

Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.

Rojas-Reyes MX, García Morales OM, Dennis RJ, Karner C.

Cochrane Database Syst Rev. 2016 Jun 6;(6):CD008532. doi: 10.1002/14651858.CD008532.pub3. Review.

PMID:
27271056
10.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

11.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
12.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
13.
14.

How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, Leff B, Kent DM, Schünemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):274-81. doi: 10.1513/pats.201208-063ST. Review.

PMID:
23256171
15.

Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.

Smith SM, Wallace E, O'Dowd T, Fortin M.

Cochrane Database Syst Rev. 2016 Mar 14;3:CD006560. doi: 10.1002/14651858.CD006560.pub3. Review.

PMID:
26976529
16.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Kesterton A.

Cochrane Database Syst Rev. 2013 Aug 30;(8):CD006826. doi: 10.1002/14651858.CD006826.pub2. Review.

PMID:
23990350
17.

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease.

Miravitlles M, Price D, Rabe KF, Schmidt H, Metzdorf N, Celli B.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 16;10:549-64. doi: 10.2147/COPD.S71913. eCollection 2015. Review.

18.

Automated telephone communication systems for preventive healthcare and management of long-term conditions.

Posadzki P, Mastellos N, Ryan R, Gunn LH, Felix LM, Pappas Y, Gagnon MP, Julious SA, Xiang L, Oldenburg B, Car J.

Cochrane Database Syst Rev. 2016 Dec 14;12:CD009921. doi: 10.1002/14651858.CD009921.pub2. Review.

PMID:
27960229
19.

Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

Walters JA, Tan DJ, White CJ, Gibson PG, Wood-Baker R, Walters EH.

Cochrane Database Syst Rev. 2014 Sep 1;(9):CD001288. doi: 10.1002/14651858.CD001288.pub4. Review.

PMID:
25178099
20.

Management of type 2 diabetes mellitus in children and adolescents.

Springer SC, Silverstein J, Copeland K, Moore KR, Prazar GE, Raymer T, Shiffman RN, Thaker VV, Anderson M, Spann SJ, Flinn SK; American Academy of Pediatrics.

Pediatrics. 2013 Feb;131(2):e648-64. doi: 10.1542/peds.2012-3496. Epub 2013 Jan 28. Review. Erratum in: Pediatrics. 2013 May;131(5):1014.

Supplemental Content

Support Center